Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Novel Biomarkers of Heart Failure.

Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T.

Adv Clin Chem. 2017;79:93-152. doi: 10.1016/bs.acc.2016.09.002.

PMID:
28212715
2.

A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.

Demissei BG, Cotter G, Prescott MF, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Severin TM, Wang Y, Qian M, Teerlink JR, Metra M, Davison BA, Voors AA.

Eur J Heart Fail. 2017 Jan 30. doi: 10.1002/ejhf.749. [Epub ahead of print]

PMID:
28133908
3.

Methods for the detection and serum depletion of porcine galectin-3.

Eliaz I, Patil A, Navarro-Alvarez N, Wang Z, Eliaz A, Weil E, Wilk B, Sachs DH, Huang CA.

J Clin Apher. 2017 Jan 13. doi: 10.1002/jca.21521. [Epub ahead of print]

PMID:
28083958
4.

Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.

Martinez-Martinez E, Ibarrola J, Calvier L, Fernandez-Celis A, Leroy C, Cachofeiro V, Rossignol P, Lopez-Andres N.

PLoS One. 2016 Nov 9;11(11):e0166272. doi: 10.1371/journal.pone.0166272.

5.

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation.

Hijazi Z, Oldgren J, Siegbahn A, Wallentin L.

Clin Chem. 2017 Jan;63(1):152-164. doi: 10.1373/clinchem.2016.255182. Review.

PMID:
27811208
6.

Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction.

Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL.

JACC Heart Fail. 2016 Nov;4(11):847-856. doi: 10.1016/j.jchf.2016.06.010.

PMID:
27614937
7.

Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.

Nie M, Bal MS, Yang Z, Liu J, Rivera C, Wenzel A, Beck BB, Sakhaee K, Marciano DK, Wolf MT.

J Am Soc Nephrol. 2016 Nov;27(11):3447-3458.

PMID:
27036738
8.

Variability of biomarkers in patients with chronic heart failure and healthy controls.

Meijers WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, Wu AH, Jaffe A, de Boer RA.

Eur J Heart Fail. 2016 Oct 21. doi: 10.1002/ejhf.669. [Epub ahead of print]

PMID:
27766733
9.

Role of galectin-3 in autoimmune and non-autoimmune nephropathies.

Saccon F, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.

Autoimmun Rev. 2017 Jan;16(1):34-47. doi: 10.1016/j.autrev.2016.09.023. Review.

PMID:
27666815
10.

Fatty Liver and Chronic Kidney Disease: Novel Mechanistic Insights and Therapeutic Opportunities.

Musso G, Cassader M, Cohney S, De Michieli F, Pinach S, Saba F, Gambino R.

Diabetes Care. 2016 Oct;39(10):1830-45. doi: 10.2337/dc15-1182. Review.

PMID:
27660122
11.

Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.

Obokata M, Sunaga H, Ishida H, Ito K, Ogawa T, Ando Y, Kurabayashi M, Negishi K.

Am Heart J. 2016 Sep;179:29-41. doi: 10.1016/j.ahj.2016.05.018.

PMID:
27595677
12.

Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.

Jansen H, Koenig W, Jaensch A, Mons U, Breitling LP, Scharnagl H, Stojakovic T, Schunkert H, Brenner H, Rothenbacher D.

Clin Chem. 2016 Oct;62(10):1372-9. doi: 10.1373/clinchem.2016.257550.

PMID:
27540030
13.

New Pharmacologic Agents That Target Inflammation and Fibrosis in Nonalcoholic Steatohepatitis-Related Kidney Disease.

Musso G, De Michieli F, Bongiovanni D, Parente R, Framarin L, Leone N, Berrutti M, Gambino R, Cassader M, Cohney S, Paschetta E.

Clin Gastroenterol Hepatol. 2016 Aug 10. pii: S1542-3565(16)30511-0. doi: 10.1016/j.cgh.2016.08.002. [Epub ahead of print]

PMID:
27521506
14.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014.

15.

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial.

Tuñón J, González-Hernández I, Llanos-Jiménez L, Alonso-Martín J, Escudier-Villa JM, Tarín N, Cristóbal C, Sanz P, Pello AM, Aceña Á, Carda R, Orejas M, Tomás M, Beltrán P, Calero Rueda M, Marcos E, Serrano-Antolín JM, Gutiérrez-Landaluce C, Jiménez R, Cabezudo J, Curcio A, Peces-Barba G, González-Parra E, Muñoz-Siscart R, González-Casaus ML, Lorenzo A, Huelmos A, Goicolea J, Ibáñez B, Hernández G, Alonso-Pulpón LM, Farré J, Lorenzo Ó, Mahíllo-Fernández I, Egido J.

BMJ Open. 2016 Aug 5;6(8):e011287. doi: 10.1136/bmjopen-2016-011287.

16.

Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout.

Balbo BE, Amaral AG, Fonseca JM, de Castro I, Salemi VM, Souza LE, Dos Santos F, Irigoyen MC, Qian F, Chammas R, Onuchic LF.

Kidney Int. 2016 Sep;90(3):580-97. doi: 10.1016/j.kint.2016.04.028.

PMID:
27475230
17.

Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.

Clerico A, Passino C, Franzini M, Emdin M.

Future Cardiol. 2016 Sep;12(5):573-84. doi: 10.2217/fca-2016-0013.

PMID:
27459871
18.

Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension.

Neumann JT, Ewen S, Mortensen K, Nef H, Zeller T, Ojeda F, Sydow K, Mahfoud F, Böhm M, Hamm C, Dörr O, Blankenberg S.

Biomark Med. 2016 Aug;10(8):841-51. doi: 10.2217/bmm-2016-0098.

PMID:
27428075
19.

Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients.

Dieplinger B, Egger M, Leitner I, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T.

J Crit Care. 2016 Aug;34:38-45. doi: 10.1016/j.jcrc.2016.03.020.

20.

Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.

Stoltze Gaborit F, Bosselmann H, Kistorp C, Iversen K, Kumler T, Gustafsson F, Goetze JP, Sölétormos G, Tønder N, Schou M.

BMC Cardiovasc Disord. 2016 May 31;16:117. doi: 10.1186/s12872-016-0290-7.

Items per page

Supplemental Content

Loading ...
Support Center